Hot Features
プレミアム
Precision BioSciences Inc (DTIL)
NASDAQ
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-20 | Mr. Kevin J. BuehlerIndependent Chairman | 21.00k | 0.00 | Derivative Exercise and Retained Stock | - | 49.14k | 74.63% |
| 2026-05-20 | Dr. Stanley R. FrankelIndependent Director | 21.00k | 0.00 | Derivative Exercise and Retained Stock | - | 40.48k | 107.81% |
| 2026-05-20 | Ms. Melinda BrownIndependent Director | 21.00k | 0.00 | Derivative Exercise and Retained Stock | - | 44.35k | 89.95% |
| 2026-05-20 | Ms. Shari Lisa PireIndependent Director | 21.00k | 0.00 | Derivative Exercise and Retained Stock | - | 35.03k | 149.70% |
| 2026-05-20 | Mr. Geno J. GermanoIndependent Director | 21.00k | 0.00 | Derivative Exercise and Retained Stock | - | 44.88k | 87.93% |
| 2026-02-17 | Mr. Dario ScimecaGeneral Counsel & Secretary | -4.93k | 18.91k | Derivative Exercise and Sale | 3.84 | 56.46k | - |
| 2026-02-17 | Mr. Michael AmorosoPresident, CEO & Director | 47.24k | 0.00 | Derivative Exercise and Retained Stock | - | 243.39k | 24.08% |
| 2026-02-17 | Mr. Michael AmorosoPresident, CEO & Director | -20.56k | 78.95k | Derivative Exercise and Sale | 3.84 | 243.39k | - |
| 2026-02-17 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | 11.74k | 0.00 | Derivative Exercise and Retained Stock | - | 129.86k | 9.94% |
| 2026-02-17 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | -4.93k | 18.91k | Derivative Exercise and Sale | 3.84 | 129.86k | - |
| 2026-02-17 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 19.44k | 0.00 | Derivative Exercise and Retained Stock | - | 125.88k | 18.26% |
| 2026-02-17 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -8.15k | 31.29k | Derivative Exercise and Sale | 3.84 | 125.88k | - |
| 2026-02-17 | Mr. Dario ScimecaGeneral Counsel & Secretary | 11.74k | 0.00 | Derivative Exercise and Retained Stock | - | 56.46k | 26.26% |
| 2026-01-20 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 29.15k | 0.00 | Derivative Exercise and Retained Stock | - | 106.45k | 37.71% |
| 2026-01-20 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -15.21k | 61.31k | Derivative Exercise and Sale | 4.03 | 106.45k | - |
| 2026-01-20 | Mr. Dario ScimecaGeneral Counsel & Secretary | 16.46k | 0.00 | Derivative Exercise and Retained Stock | - | 44.72k | 58.24% |
| 2026-01-20 | Mr. Dario ScimecaGeneral Counsel & Secretary | -8.85k | 35.68k | Derivative Exercise and Sale | 4.03 | 44.72k | - |
| 2026-01-20 | Mr. Michael AmorosoPresident, CEO & Director | 80.58k | 0.00 | Derivative Exercise and Retained Stock | - | 196.15k | 69.72% |
| 2026-01-20 | Mr. Michael AmorosoPresident, CEO & Director | -34.80k | 145.11k | Derivative Exercise and Sale | 4.17 | 196.15k | - |
| 2026-01-20 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | 18.97k | 0.00 | Derivative Exercise and Retained Stock | - | 118.12k | 19.13% |
| 2026-01-21 | Dr. Jefferson J. SmithCo-Founder & Chief Research Officer | -10.20k | 41.11k | Derivative Exercise and Sale | 4.03 | 118.12k | - |
| 2025-12-16 | Mr. Geno J. GermanoIndependent Director | 3.00k | 14.16k | 買い | 4.72 | 23.88k | 14.37% |
| 2025-12-15 | Ms. Melinda BrownIndependent Director | 1.38k | 6.86k | 買い | 4.97 | 23.35k | 6.29% |
| 2025-12-16 | Dr. Stanley R. FrankelIndependent Director | 2.70k | 12.69k | 買い | 4.70 | 19.48k | 16.09% |
| 2025-11-02 | Mr. Dario ScimecaGeneral Counsel & Secretary | 1.17k | 0.00 | Derivative Exercise and Retained Stock | - | 28.26k | 4.32% |
| 2025-11-02 | Mr. Dario ScimecaGeneral Counsel & Secretary | -665.00 | 4.32k | Derivative Exercise and Sale | 6.49 | 28.26k | - |
| 2025-11-02 | Mr. John Alexander KellyCFO & Principal Accounting Officer | 2.30k | 0.00 | Derivative Exercise and Retained Stock | - | 77.30k | 3.07% |
| 2025-11-02 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -1.30k | 8.46k | Derivative Exercise and Sale | 6.49 | 77.30k | - |
| 2025-11-02 | Mr. Michael AmorosoPresident, CEO & Director | 6.04k | 0.00 | Derivative Exercise and Retained Stock | - | 115.58k | 5.51% |
| 2025-11-02 | Mr. Michael AmorosoPresident, CEO & Director | -3.41k | 22.12k | Derivative Exercise and Sale | 6.49 | 115.58k | - |
| 2025-09-26 | Dr. Stanley R. FrankelIndependent Director | 2.70k | 13.42k | 買い | 4.97 | 16.78k | 19.18% |
| 2025-09-22 | Ms. Melinda BrownIndependent Director | 1.40k | 6.85k | 買い | 4.89 | 21.97k | 6.81% |
| 2025-07-03 | Mr. John Alexander KellyCFO & Principal Accounting Officer | -14.83k | 63.16k | Automatic Disposition | 4.26 | 73.49k | -16.79% |
| 2025-06-25 | Ms. Melinda BrownIndependent Director | 1.68k | 6.96k | 買い | 4.14 | 20.57k | 8.91% |
| 2025-06-25 | Mr. Kevin J. BuehlerIndependent Chairman | 5.08k | 21.12k | 買い | 4.16 | 28.14k | 22.01% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
